Conestat alfa (ruconest): first recombinant c1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema.

Conestat alfa (Ruconest): first recombinant C1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema.

[1]  P. Kawalec,et al.  Cost-utility analysis of Ruconest® (conestat alfa) compared to Berinert® P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema , 2013, Postepy dermatologii i alergologii.

[2]  A. Kaplan.  Type III hereditary angioedema: defined, but not understood. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  T. Craig,et al.  Update on treatment of hereditary angioedema. , 2012, Asian Pacific journal of allergy and immunology.

[4]  K. Bork.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[5]  W. Kittisupamongkol.  Normal C1 inhibitor hereditary angioedema. , 2009, The American journal of medicine.

[6]  A. Lehmann.  Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery , 2008 .

[7]  F. Simons.  Emergency treatment of anaphylaxis , 2008, BMJ : British Medical Journal.

[8]  J. Bernstein.  Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  J. J. S. Sienra Monge,et al.  [Urticaria and angioedema]. , 2007, Revista alergia Mexico.

[10]  A. Eerenberg,et al.  A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.

[11]  C. Hack,et al.  C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. , 2000, Pharmacological reviews.